HER2 in high-risk rectal cancer patients treated in EXPERT-C, a randomized phase II trial of neoadjuvant capecitabine and oxaliplatin (CAPOX) and chemoradiotherapy (CRT) with or without cetuximab
Sclafani, Francesco, Roy, Amitesh Chandra, Chau, Ian, Wotherspoon, Andrew, Peckitt, Clare, Dewdney, Alice, Oates, Jacqueline Rose, Cunningham, David
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Panex: A pooled analysis of EXPERT and EXPERT-C, two trials of neoadjuvant chemotherapy (NACT) and chemoradiotherapy (CRT) in high-risk locally advanced rectal cancer (LARC)
Sclafani, Francesco, Peckitt, Clare, Cunningham, David, Evans, Jessica, Brown, Gina, Tabernero, Josep, Glimelius, Bengt, Cervantes, Andres, Tait, Diana M., Wotherspoon, Andrew, Thomas, Janet, Oates, Jacqueline Rose, Chau, Ian
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
HER-2 in high risk rectal cancer patients treated in EXPERT-C, a randomized phase II trial of neoadjuvant capecitabine and oxaliplatin (CAPOX) and chemoradiotherapy (CRT) with or without cetuximab
Sclafani, Francesco, Roy, Amitesh Chandra, Chau, Ian, Wotherspoon, Andrew, Peckitt, Clare, Dewdney, Alice, Oates, Jacqueline Rose, Cunningham, David
Published in Journal of clinical oncology (01.02.2013)
Published in Journal of clinical oncology (01.02.2013)
Get full text
Journal Article
FCγRIIa and FCγRIIIa polymorphisms (SNPs) and cetuximab (C) benefit in the EXPERT-C trial
Sclafani, Francesco, Gonzalez de Castro, David, Cunningham, David, Hulkki Wilson, Sanna, Peckitt, Clare, Capdevila, Jaume, Glimelius, Bengt, Rosello Keranen, Susana, Begum, Ruwaida, Brown, Gina, Tait, Diana M., Wotherspoon, Andrew, Thomas, Janet, Oates, Jacqueline Rose, Chau, Ian
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Relationship of RAS and TP53 predictive value for cetuximab (C) benefit: Results of the EXPERT-C trial
Sclafani, Francesco, Gonzalez, David, Cunningham, David, Hullki Wilson, Sanna, Peckitt, Clare, Tabernero, Josep, Glimelius, Bengt, Cervantes, Andres, Wotherspoon, Andrew, Dewdney, Alice, Brown, Gina, Tait, Diana M., Oates, Jacqueline Rose, Chau, Ian
Published in Journal of clinical oncology (20.01.2014)
Published in Journal of clinical oncology (20.01.2014)
Get full text
Journal Article
RAS mutations in EXPERT-C, a randomized phase II trial of neoadjuvant capecitabine and oxaliplatin (CAPOX) and chemoradiotherapy (CRT) with or without cetuximab (C) in MRI-defined, high-risk rectal cancer (RC)
Sclafani, Francesco, Gonzalez, David, Cunningham, David, Hullki Wilson, Sanna, Peckitt, Clare, Tabernero, Josep, Glimelius, Bengt, Cervantes, Andres, Wotherspoon, Andrew, Brown, Gina, Tait, Diana M., Oates, Jacqueline Rose, Chau, Ian
Published in Journal of clinical oncology (20.01.2014)
Published in Journal of clinical oncology (20.01.2014)
Get full text
Journal Article
FC gamma RIIa and FC gamma RIIa polymorphisms (SNPs) and cetuximab (C) benefit in the EXPERT-C trial
Sclafani, Francesco, Gonzalez de Castro, David, Cunningham, David, Wilson, Sanna Hulkki, Peckitt, Clare, Capdevila, Jaume, Glimelius, Bengt, Keranen, Susana Rosello, Begum, Ruwaida, Brown, Gina, Tait, Diana M., Wotherspoon, Andrew, Thomas, Janet, Oates, Jacqueline Rose, Chau, Lan
Published in Journal of clinical oncology (2014)
Get full text
Published in Journal of clinical oncology (2014)
Journal Article
Prognostic effect of a single nucleotide polymorphism (SNP) in MIR608 in patients with high-risk locally advanced rectal cancer (LARC): Results of the EXPERT-C trial
Sclafani, Francesco, Chau, Ian, Cunningham, David, Lampis, Andrea, Hahne, Jens, Braconi, Chiara, Peckitt, Clare, Gonzalez, David, Hullki Wilson, Sanna, Capdevila, Jaume, Glimelius, Bengt, Cervantes, Andres, Begum, Ruwaida, Brown, Gina, Tait, Diana M., Wotherspoon, Andrew, Eltahir, Zakaria, Yusuf-Adam, Sandra, Oates, Jacqueline Rose, Valeri, Nicola
Published in Journal of clinical oncology (20.01.2015)
Published in Journal of clinical oncology (20.01.2015)
Get full text
Journal Article
The impact of TP53 mutation on high-risk rectal cancer patients treated within the EXPERT-C trial, a randomized phase II study of neoadjuvant oxaliplatin/capecitabine (CAPOX) and chemoradiation (CRT) with or without cetuximab
Dewdney, Alice, Chau, Ian, Capdevila, Jaume, Glimelius, Bengt, Cervantes-Ruiperez, Andres, Tait, Diana M., Brown, Gina, Wotherspoon, Andrew, Gonzalez de Castro, David, Hulkki Wilson, Sanna, Chua, Yu Jo, Wong, Rachel, Barbachano, Yolanda, Oates, Jacqueline Rose, Cunningham, David
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article